This article will be permanently flagged as inappropriate and made unaccessible to everyone. Are you certain this article is inappropriate? Excessive Violence Sexual Content Political / Social
Email Address:
Article Id: WHEBN0026927153 Reproduction Date:
EXP-561[1] is a drug which acts as an inhibitor of the reuptake of serotonin, dopamine, and norepinephrine.[2][3][4][5] It was developed in the 1960s by Du Pont[6] and was suggested as a potential antidepressant but failed in trials[7] and was never marketed.[5][8][9][10]
: PSO/PSI
(, , , , , , ), /,
proc (/), drug (/////)
* Note that many TCAs, TeCAs, antipsychotics, ergolines, and some piperazines like buspirone and trazodone all antagonize α1-adrenergic receptors as well, which contributes to their side effects such as orthostatic hypotension.
* Note that many atypical antipsychotics and azapirones like buspirone (via metabolite 1-PP) antagonize α2-adrenergic receptors as well.
* Note that MAO-B inhibitors also influence norepinephrine/epinephrine levels since they inhibit the breakdown of their precursor dopamine.
Methamphetamine, Addiction, Norepinephrine, Gene expression, PubChem
Amphetamine, Methylphenidate, Cocaine, Ethanol, Norepinephrine
International Standard Serial Number, Brill's New Pauly, John Peter Oleson
Copper, Periodic table, Cadmium, Iron, Lead
Amphetamine, Cocaine, Iron, Zinc, Methamphetamine
Amphetamine, Methamphetamine, Digital object identifier, L-dopa, Norepinephrine
Cocaine, Iron, Zinc, Lysergic acid diethylamide, 5-Carboxamidotryptamine
Amphetamine, Methamphetamine, Lysergic acid diethylamide, Iron, Zinc
Methamphetamine, Amphetamine, Lysergic acid diethylamide, Iron, Zinc